{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:51:23Z","timestamp":1786978283159,"version":"build-2736575974"},"reference-count":258,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T00:00:00Z","timestamp":1615766400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Blood &amp; Cancer"],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Larger clinical trial enrollments and a greater understanding of biological heterogeneity have led to improved survival rates for children diagnosed with brain tumors in the last 50 years. However, reducing long\u2010term morbidities and improving survival rates of high\u2010risk tumors remain major challenges. Chemotherapy can reduce tumor burden, but effective drug penetration at the tumor site is limited by barriers in the route of drug administration and within the tumor microenvironment. Bioavailability of drugs is impeded by the blood\u2010brain barrier, plasma protein binding, and structural components by the tumor including the matrix and vasculature contributing to increased interstitial fluid pressure, hypoxia, and acidity. Designing drug delivery systems to circumvent these barriers could lead to improved drug penetration at the tumor site and reduce adverse systemic side effects. In this review, we expand on how systemic and local barriers limit drug penetration and present potential methods to enhance drug penetration in pediatric brain tumors.<\/jats:p>","DOI":"10.1002\/pbc.28983","type":"journal-article","created":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T03:42:23Z","timestamp":1615779743000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Drug penetration in pediatric brain tumors: Challenges and opportunities"],"prefix":"10.1002","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9395-8071","authenticated-orcid":false,"given":"Jenny P.","family":"Patel","sequence":"first","affiliation":[{"name":"Department of Mechanical, Aerospace, and Biomedical Engineering The University of Tennessee at Knoxville Knoxville Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Spiller","sequence":"additional","affiliation":[{"name":"Pediatric Hematology\/Oncology East Tennessee Children's Hospital Knoxville Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth D.","family":"Barker","sequence":"additional","affiliation":[{"name":"Department of Mechanical, Aerospace, and Biomedical Engineering The University of Tennessee at Knoxville Knoxville Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,3,15]]},"reference":[{"issue":"6","key":"e_1_2_7_2_1","first-page":"1","article-title":"Death: final data for 2015","volume":"66","author":"Murphy SL","year":"2017","journal-title":"Natl Vital Stat Reports"},{"issue":"4","key":"e_1_2_7_3_1","first-page":"1","article-title":"National vital statistics reports \u2013 deaths: final data for 2014","volume":"65","author":"Kochanek KD","year":"2016","journal-title":"Natl Vital Stat Reports"},{"issue":"2","key":"e_1_2_7_4_1","first-page":"1","article-title":"Deaths: final data for 2013","volume":"64","author":"Xu J","year":"2016","journal-title":"Natl Vital Stat Reports"},{"issue":"9","key":"e_1_2_7_5_1","first-page":"1","article-title":"Deaths: final data for 2012","volume":"63","author":"Murphy SL","year":"2015","journal-title":"Natl Vital Stat Reports"},{"issue":"3","key":"e_1_2_7_6_1","first-page":"1","article-title":"National vital statistics reports deaths: final data for 2011","volume":"63","author":"Kochanek KD","year":"2015","journal-title":"Natl Vital Stat Reports"},{"key":"e_1_2_7_7_1","volume-title":"SEER cancer statistics review, 1975\u20102015","author":"Noone A"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.1404"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nox158"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31610-0"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-12-214"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1893"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/PPO.0000000000000125"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djj070"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2006.06.007"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aaf7593"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2287"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature25480"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.3171\/2018.10.PEDS18377"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-chembioeng-061010-114300"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-409X(00)00131-9"},{"issue":"12","key":"e_1_2_7_22_1","first-page":"3039","article-title":"Transport of molecules in the tumor interstitium: a review","volume":"47","author":"Jain RK","year":"1987","journal-title":"Cancer Res"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00047468"},{"issue":"10","key":"e_1_2_7_24_1","first-page":"2814","article-title":"Diffusion and convection in normal and neoplastic tissues","volume":"34","author":"Swabb EA","year":"1974","journal-title":"Cancer Res"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2011.95"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2017.93"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-010-0103-9"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.4161\/tisb.29528"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2014.05.004"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics3010053"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2017.09.016"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky1033"},{"issue":"7","key":"e_1_2_7_33_1","first-page":"1605","article-title":"Understanding barriers to drug delivery: high resolution in vivo imaging is key","volume":"5","author":"Jain RK","year":"1999","journal-title":"Clin Cancer Res"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.5b09974"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2018.02.005"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.5863\/1551-6776-19.4.262"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1592\/phco.29.6.680"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M116.066720"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017213"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1472-8206.2003.00140.x"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1177\/0883073809342491"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1177\/0883073815587944"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nos202"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(04)01507-4"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nov164"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-013-1196-z"},{"key":"e_1_2_7_47_1","article-title":"Drug delivery to the central nervous system: a review","author":"Misra A","year":"2003","journal-title":"J Pharm Pharm Sci"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2012.00046"},{"key":"e_1_2_7_49_1","doi-asserted-by":"publisher","DOI":"10.1602\/neurorx.2.1.86"},{"key":"e_1_2_7_50_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-019-0205-x"},{"key":"e_1_2_7_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-812100-9.00008-5"},{"key":"e_1_2_7_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-803058-5.00009-6"},{"issue":"6","key":"e_1_2_7_53_1","first-page":"11","article-title":"Pathways for small molecule delivery to the central nervous system across the blood\u2010brain barrier","volume":"6","author":"Mikitsh JL","year":"2014","journal-title":"Perspect Medicin Chem"},{"key":"e_1_2_7_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-409X(00)00129-0"},{"key":"e_1_2_7_55_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00232-015-9778-9"},{"key":"e_1_2_7_56_1","doi-asserted-by":"publisher","DOI":"10.1602\/neurorx.2.4.541"},{"key":"e_1_2_7_57_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm501535r"},{"key":"e_1_2_7_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2017.08.001"},{"key":"e_1_2_7_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2016.03.002"},{"key":"e_1_2_7_60_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1984"},{"key":"e_1_2_7_61_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-018-0690-x"},{"key":"e_1_2_7_62_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0192180"},{"key":"e_1_2_7_63_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-015-2924-3"},{"key":"e_1_2_7_64_1","doi-asserted-by":"publisher","DOI":"10.2174\/1871520616666151120121928"},{"key":"e_1_2_7_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxlet.2010.04.025"},{"key":"e_1_2_7_66_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1633"},{"key":"e_1_2_7_67_1","volume-title":"Pediatric and Neonatal Lexi\u2010Drugs Online","author":"Online L"},{"key":"e_1_2_7_68_1","doi-asserted-by":"crossref","unstructured":"GlodJ RahmeGJ KaurH RaabeE HwangEI IsraelMA.Pediatric Brain Tumors: Current Knowledge and Therapeutic Opportunities.https:\/\/doi.org\/10.1097\/MPH.0000000000000551.","DOI":"10.1097\/MPH.0000000000000551"},{"key":"e_1_2_7_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2005.04.006"},{"key":"e_1_2_7_70_1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noq056"},{"key":"e_1_2_7_71_1","doi-asserted-by":"publisher","DOI":"10.1215\/S1152851703000516"},{"key":"e_1_2_7_72_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1213353109"},{"issue":"16","key":"e_1_2_7_73_1","first-page":"4136","article-title":"Available volume fraction of macromolecules in the extravascular space of a fibrosarcoma: implications for drug delivery","volume":"59","author":"Krol A","year":"1999","journal-title":"Cancer Res"},{"key":"e_1_2_7_74_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djm135"},{"key":"e_1_2_7_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/0026-2862(89)90074-5"},{"key":"e_1_2_7_76_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2017.83"},{"key":"e_1_2_7_77_1","doi-asserted-by":"publisher","DOI":"10.1186\/2045-8118-8-7"},{"key":"e_1_2_7_78_1","doi-asserted-by":"publisher","DOI":"10.1021\/mp300495e"},{"key":"e_1_2_7_79_1","volume-title":"Drug Delivery to the Brain","author":"Pardridge WM","year":"1997"},{"key":"e_1_2_7_80_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1877"},{"key":"e_1_2_7_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2010.02.045"},{"key":"e_1_2_7_82_1","doi-asserted-by":"publisher","DOI":"10.3109\/08880018.2012.698372"},{"key":"e_1_2_7_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2017.02.009"},{"key":"e_1_2_7_84_1","doi-asserted-by":"publisher","DOI":"10.1111\/febs.12109"},{"key":"e_1_2_7_85_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3726"},{"key":"e_1_2_7_86_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.46.3653"},{"key":"e_1_2_7_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.01.036"},{"key":"e_1_2_7_88_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2017.166"},{"key":"e_1_2_7_89_1","doi-asserted-by":"publisher","DOI":"10.3171\/2009.11.PEDS09260"},{"key":"e_1_2_7_90_1","doi-asserted-by":"publisher","DOI":"10.1177\/153303460400300607"},{"key":"e_1_2_7_91_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-016-0632-1"},{"key":"e_1_2_7_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2008.10.026"},{"key":"e_1_2_7_93_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2001-13872"},{"key":"e_1_2_7_94_1","doi-asserted-by":"publisher","DOI":"10.1038\/35025220"},{"key":"e_1_2_7_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0736-5748(99)00025-8"},{"key":"e_1_2_7_96_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1549-8719.2000.tb00138.x"},{"key":"e_1_2_7_97_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2990.2010.01113.x"},{"key":"e_1_2_7_98_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1013181107707"},{"key":"e_1_2_7_99_1","doi-asserted-by":"publisher","DOI":"10.1038\/427695a"},{"key":"e_1_2_7_100_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.bioeng.1.1.241"},{"key":"e_1_2_7_101_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00046364"},{"key":"e_1_2_7_102_1","doi-asserted-by":"publisher","DOI":"10.3109\/10739689709148315"},{"key":"e_1_2_7_103_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2990.2011.01160.x"},{"key":"e_1_2_7_104_1","doi-asserted-by":"publisher","DOI":"10.1215\/15228517-2007-032"},{"key":"e_1_2_7_105_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc704"},{"key":"e_1_2_7_106_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-017-0061-0"},{"key":"e_1_2_7_107_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-13-331"},{"key":"e_1_2_7_108_1","doi-asserted-by":"publisher","DOI":"10.1021\/mp200292c"},{"key":"e_1_2_7_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2011.11.031"},{"key":"e_1_2_7_110_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-1173-1_1"},{"key":"e_1_2_7_111_1","doi-asserted-by":"publisher","DOI":"10.2174\/1381612822666151221150733"},{"key":"e_1_2_7_112_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00172455"},{"key":"e_1_2_7_113_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2007.00988.x"},{"key":"e_1_2_7_114_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006123-199805000-00082"},{"key":"e_1_2_7_115_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23221"},{"key":"e_1_2_7_116_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(20000201)88:3<637::AID-CNCR22>3.0.CO;2-Y"},{"issue":"1","key":"e_1_2_7_117_1","first-page":"48","article-title":"Intra\u2010arterial chemotherapy with osmotic blood\u2010brain barrier disruption for aggressive oligodendroglial tumors: results of a phase I study","volume":"66","author":"Guillaume DJ","year":"2010","journal-title":"Neurosurgery"},{"key":"e_1_2_7_118_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-812100-9.00010-3"},{"key":"e_1_2_7_119_1","doi-asserted-by":"publisher","DOI":"10.1227\/01.NEU.0000097715.11966.8E"},{"key":"e_1_2_7_120_1","doi-asserted-by":"publisher","DOI":"10.1016\/bs.apha.2014.06.002"},{"key":"e_1_2_7_121_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006123-199810000-00090"},{"issue":"6","key":"e_1_2_7_122_1","first-page":"1549","article-title":"Differential permeability of a human brain tumor xenograft in the nude rat: impact of tumor size and method of administration on optimizing delivery of biologically diverse agents","volume":"4","author":"Neuwelt EA","year":"1998","journal-title":"Clin Cancer Res"},{"key":"e_1_2_7_123_1","doi-asserted-by":"publisher","DOI":"10.1097\/01376517-199804000-00002"},{"key":"e_1_2_7_124_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3407"},{"key":"e_1_2_7_125_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-005-9038-4"},{"key":"e_1_2_7_126_1","doi-asserted-by":"publisher","DOI":"10.3171\/2010.9.JNS101223"},{"key":"e_1_2_7_127_1","doi-asserted-by":"publisher","DOI":"10.3171\/2016.6.JNS16537"},{"key":"e_1_2_7_128_1","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0b013e318282dc70"},{"key":"e_1_2_7_129_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00239"},{"key":"e_1_2_7_130_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMct1206321"},{"key":"e_1_2_7_131_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2014.01.008"},{"key":"e_1_2_7_132_1","doi-asserted-by":"publisher","DOI":"10.1038\/pr.2013.194"},{"issue":"2","key":"e_1_2_7_133_1","first-page":"110","article-title":"The potential for complete and durable response in nonglial primary brain tumors in children and young adults with enhanced chemotherapy delivery","volume":"4","author":"Dahlborg SA","year":"1998","journal-title":"Cancer J Sci Am"},{"key":"e_1_2_7_134_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-008-9018-7"},{"key":"e_1_2_7_135_1","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.1996.0156"},{"key":"e_1_2_7_136_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006123-199902000-00015"},{"key":"e_1_2_7_137_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002620050328"},{"key":"e_1_2_7_138_1","doi-asserted-by":"publisher","DOI":"10.1080\/01616412.1992.11740093"},{"key":"e_1_2_7_139_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-5728(95)00148-4"},{"key":"e_1_2_7_140_1","doi-asserted-by":"publisher","DOI":"10.1179\/016164101101198596"},{"key":"e_1_2_7_141_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00462"},{"key":"e_1_2_7_142_1","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.1999.7247"},{"key":"e_1_2_7_143_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002800050042"},{"key":"e_1_2_7_144_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0317167100036301"},{"key":"e_1_2_7_145_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-005-0172-7"},{"key":"e_1_2_7_146_1","doi-asserted-by":"publisher","DOI":"10.1227\/00006123-199507000-00003"},{"issue":"3","key":"e_1_2_7_147_1","first-page":"493","article-title":"Delayed sodium thiosulfate as an otoprotectant against carboplatin\u2010induced hearing loss in patients with malignant brain tumors","volume":"7","author":"Doolittle ND","year":"2001","journal-title":"Clin Cancer Res"},{"key":"e_1_2_7_148_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006123-200007000-00041"},{"key":"e_1_2_7_149_1","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2202001804"},{"key":"e_1_2_7_150_1","doi-asserted-by":"publisher","DOI":"10.3171\/2015.4.JNS142893"},{"key":"e_1_2_7_151_1","doi-asserted-by":"publisher","DOI":"10.3171\/2019.10.FOCUS19726"},{"key":"e_1_2_7_152_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf6086"},{"key":"e_1_2_7_153_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061512"},{"key":"e_1_2_7_154_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2009.07.029"},{"key":"e_1_2_7_155_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2015.02.002"},{"key":"e_1_2_7_156_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-015-0266-y"},{"key":"e_1_2_7_157_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2012.05.028"},{"key":"e_1_2_7_158_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2012.05.038"},{"key":"e_1_2_7_159_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2005.01.022"},{"key":"e_1_2_7_160_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.109.154781"},{"key":"e_1_2_7_161_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.11.4017"},{"key":"e_1_2_7_162_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200443020-00002"},{"key":"e_1_2_7_163_1","unstructured":"A study of ribociclib and everolimus following radiation therapy in children with newly diagnosed non\u2010biopsied diffuse pontine gliomas (DIPG) and RB+ biopsied DIPG and high\u2010grade gliomas (HGG).https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03355794. Identifier: NCT03355794. Accessed December 21 2020."},{"key":"e_1_2_7_164_1","unstructured":"A study of panobinostat in combination with everolimus for children and young adults with gliomas.https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03632317. Identifier: NCT03632317. Accessed December 21 2020."},{"key":"e_1_2_7_165_1","unstructured":"Trametinib and everolimus for the treatment of pediatric and young adult patients with recurrent low grade gliomas (PNOC021).https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04485559. Identifier: NCT04485559. Accessed December 21 2020."},{"key":"e_1_2_7_166_1","unstructured":"Study of lenvatinib in combination with everolimus in recurrent and refractory pediatric solid tumors including central nervous system tumors.https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03245151. Identifier: NCT03245151. Accessed December 21 2020."},{"key":"e_1_2_7_167_1","unstructured":"Everolimus for children with recurrent or progressive ependymoma.https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02155920. Identifier: NCT02155920. Accessed December 21 2020."},{"key":"e_1_2_7_168_1","unstructured":"PNOC 001: phase II study of everolimus for recurrent or progressive low\u2010grade gliomas in children.https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01734512. Identifier: NCT01734512. Accessed December 21 2020."},{"key":"e_1_2_7_169_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1104819"},{"key":"e_1_2_7_170_1","doi-asserted-by":"publisher","DOI":"10.1038\/scientificamerican0214-46"},{"key":"e_1_2_7_171_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrn2175"},{"key":"e_1_2_7_172_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-010-0444-x"},{"key":"e_1_2_7_173_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.26.8789"},{"key":"e_1_2_7_174_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.22868"},{"key":"e_1_2_7_175_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24006"},{"key":"e_1_2_7_176_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24297"},{"key":"e_1_2_7_177_1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noq033"},{"key":"e_1_2_7_178_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.76.0611"},{"key":"e_1_2_7_179_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28283"},{"key":"e_1_2_7_180_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2013.09.005"},{"key":"e_1_2_7_181_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.23750"},{"key":"e_1_2_7_182_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(01)00225-8"},{"key":"e_1_2_7_183_1","unstructured":"Vinblastine +\/\u2010 bevacizumab in children with unresectable or progressive low grade glioma (LGG).https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02840409. Identifier: NCT02840409. Accessed December 31 2020."},{"key":"e_1_2_7_184_1","unstructured":"Temozolomide and irinotecan hydrochloride with or without bevacizumab in treating young patients with recurrent or refractory medulloblastoma or CNS primitive neuroectodermal tumors.https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01217437. Identifier: NCT01217437. Accessed December 31 2020."},{"key":"e_1_2_7_185_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12420-1"},{"key":"e_1_2_7_186_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2019.05.009"},{"key":"e_1_2_7_187_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0901352"},{"key":"e_1_2_7_188_1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noz077"},{"key":"e_1_2_7_189_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1535-6108(03)00276-9"},{"key":"e_1_2_7_190_1","doi-asserted-by":"publisher","DOI":"10.1016\/0142-9612(81)90059-4"},{"key":"e_1_2_7_191_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2017.00057"},{"key":"e_1_2_7_192_1","doi-asserted-by":"publisher","DOI":"10.1177\/0883073808321064"},{"key":"e_1_2_7_193_1","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X14666160614093615"},{"key":"e_1_2_7_194_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30322-X"},{"key":"e_1_2_7_195_1","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000000806"},{"key":"e_1_2_7_196_1","doi-asserted-by":"publisher","DOI":"10.3171\/2012.10.PEDS12142"},{"issue":"31","key":"e_1_2_7_197_1","article-title":"Treatment strategies in diffuse midline gliomas with the H3K27M mutation: the role of convection\u2010enhanced delivery in overcoming anatomic challenges","volume":"9","author":"Himes BT","year":"2019","journal-title":"Front Oncol"},{"key":"e_1_2_7_198_1","doi-asserted-by":"publisher","DOI":"10.3171\/2018.2.PEDS17663"},{"key":"e_1_2_7_199_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0169485"},{"key":"e_1_2_7_200_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneumeth.2018.08.029"},{"key":"e_1_2_7_201_1","doi-asserted-by":"publisher","DOI":"10.3171\/JNS-07\/07\/0190"},{"key":"e_1_2_7_202_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00701-013-1700-6"},{"key":"e_1_2_7_203_1","doi-asserted-by":"publisher","DOI":"10.3171\/2013.11.PEDS136"},{"key":"e_1_2_7_204_1","doi-asserted-by":"publisher","DOI":"10.3171\/jns.2004.100.3.0472"},{"key":"e_1_2_7_205_1","doi-asserted-by":"publisher","DOI":"10.3171\/2019.10.FOCUS19679"},{"key":"e_1_2_7_206_1","doi-asserted-by":"publisher","DOI":"10.4103\/2152-7806.151337"},{"key":"e_1_2_7_207_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-014-1531-1"},{"key":"e_1_2_7_208_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-015-1878-y"},{"key":"e_1_2_7_209_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197507242930402"},{"key":"e_1_2_7_210_1","unstructured":"About your ommaya reservoir placement surgery for pediatric patients. Memorial Sloan Kettering Cancer Center.https:\/\/www.mskcc.org\/cancer\u2010care\/patient\u2010education\/about\u2010your\u2010ommaya\u2010reservoir\u2010placement. Accessed August 4 2020."},{"key":"e_1_2_7_211_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2016.10.022"},{"key":"e_1_2_7_212_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa042176"},{"key":"e_1_2_7_213_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.00845"},{"key":"e_1_2_7_214_1","doi-asserted-by":"publisher","DOI":"10.3109\/02688697.2012.741732"},{"key":"e_1_2_7_215_1","doi-asserted-by":"publisher","DOI":"10.3171\/2015.2.PEDS14656"},{"key":"e_1_2_7_216_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1621738"},{"key":"e_1_2_7_217_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00381-005-1208-3"},{"key":"e_1_2_7_218_1","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1996.84.1.0124"},{"key":"e_1_2_7_219_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00381-005-1226-1"},{"key":"e_1_2_7_220_1","doi-asserted-by":"publisher","DOI":"10.3171\/2010.1.FOCUS09310"},{"key":"e_1_2_7_221_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0035-1565271"},{"key":"e_1_2_7_222_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2013.11.014"},{"key":"e_1_2_7_223_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26384"},{"key":"e_1_2_7_224_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-198702000-00008"},{"key":"e_1_2_7_225_1","doi-asserted-by":"publisher","DOI":"10.1002\/aic.690491202"},{"key":"e_1_2_7_226_1","unstructured":"GLIADEL\u00ae WAFER (Carmustine Implant) for Intracranial Use.;2003.https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2003\/20\u2010637s016_Gliadel.cfm. Accessed August 4 2020."},{"key":"e_1_2_7_227_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)90755-6"},{"key":"e_1_2_7_228_1","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1991.74.3.0441"},{"key":"e_1_2_7_229_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01060217"},{"issue":"4","key":"e_1_2_7_230_1","first-page":"672","article-title":"Pharmacokinetics of interstitial delivery of carmustine, 4\u2010hydroperoxycyclophosphamide, and paclitaxel from a biodegradable polymer implant in the monkey brain","volume":"58","author":"Fung LK","year":"1998","journal-title":"Cancer Res"},{"key":"e_1_2_7_231_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-015-1724-2"},{"key":"e_1_2_7_232_1","first-page":"3341","article-title":"The role of Gliadel wafers in the treatment of newly diagnosed GBM: a meta\u2010analysis","volume":"9","author":"Xing WK","year":"2015","journal-title":"Drug Des Devel Ther"},{"issue":"2","key":"e_1_2_7_233_1","doi-asserted-by":"crossref","DOI":"10.2217\/cns-2017-0036","article-title":"Rationale and design of the 500\u2010patient, 3\u2010year, and prospective Vigilant ObservatIon of GlIadeL WAfer ImplaNT registry Summary points","volume":"7","author":"Lillehei KO","year":"2017","journal-title":"CNS Oncol."},{"key":"e_1_2_7_234_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-016-0975-5"},{"issue":"5","key":"e_1_2_7_235_1","first-page":"1219","article-title":"Intracavitary chemotherapy (Gliadel\u00ae) and oral low\u2010dose etoposide for recurrent anaplastic ependymoma","volume":"19","author":"Sardi I","year":"2008","journal-title":"Oncol Rep"},{"key":"e_1_2_7_236_1","doi-asserted-by":"publisher","DOI":"10.1038\/natrevmats.2016.71"},{"key":"e_1_2_7_237_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-chembioeng-073009-100847"},{"key":"e_1_2_7_238_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2012.09.010"},{"key":"e_1_2_7_239_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0939-6411(00)00090-4"},{"key":"e_1_2_7_240_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.polymer.2008.01.027"},{"key":"e_1_2_7_241_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.5b09112"},{"key":"e_1_2_7_242_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2015.03.001"},{"key":"e_1_2_7_243_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S195336"},{"key":"e_1_2_7_244_1","doi-asserted-by":"publisher","DOI":"10.1002\/anie.200902672"},{"key":"e_1_2_7_245_1","doi-asserted-by":"publisher","DOI":"10.1039\/C6NR05055G"},{"key":"e_1_2_7_246_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2016.12.017"},{"key":"e_1_2_7_247_1","doi-asserted-by":"publisher","DOI":"10.1038\/natrevmats.2016.14"},{"key":"e_1_2_7_248_1","unstructured":"MTX110 by convection\u2010enhanced delivery in treating participants with newly\u2010diagnosed diffuse intrinsic pontine glioma.https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03566199Identifier: NCT03566199. Published 2018. Accessed August 4 2020."},{"key":"e_1_2_7_249_1","unstructured":"CED of MTX110 newly diagnosed diffuse midline gliomas. ClinicalTrials.gov.https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04264143. Identifier: NCT04264143. Published 2020. Accessed August 4 2020."},{"key":"e_1_2_7_250_1","unstructured":"CED with irinotecan liposome injection using real time imaging in children with diffuse intrinsic pontine glioma (DIPG).https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03086616. Identifier: NCT03086616. Accessed August 4 2020."},{"key":"e_1_2_7_251_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-017-2681-8"},{"key":"e_1_2_7_252_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-016-1958-5"},{"key":"e_1_2_7_253_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2010.139"},{"key":"e_1_2_7_254_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.8b03684"},{"key":"e_1_2_7_255_1","doi-asserted-by":"publisher","DOI":"10.1203\/PDR.0b013e3181d61ed2"},{"key":"e_1_2_7_256_1","doi-asserted-by":"publisher","DOI":"10.1203\/PDR.0b013e3181d68e78"},{"key":"e_1_2_7_257_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2019.08.008"},{"key":"e_1_2_7_258_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2015.07.044"},{"issue":"3","key":"e_1_2_7_259_1","first-page":"878","article-title":"Limited penetration of anticancer drugs through tumor tissue: a potential cause of resistance of solid tumors to chemotherapy","volume":"8","author":"Tannock IF","year":"2002","journal-title":"Clin Cancer Res"}],"container-title":["Pediatric Blood &amp; Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pbc.28983","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/pbc.28983","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pbc.28983","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,25]],"date-time":"2024-08-25T20:13:54Z","timestamp":1724616834000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pbc.28983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,15]]},"references-count":258,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["10.1002\/pbc.28983"],"URL":"https:\/\/doi.org\/10.1002\/pbc.28983","archive":["Portico"],"relation":{},"ISSN":["1545-5009","1545-5017"],"issn-type":[{"value":"1545-5009","type":"print"},{"value":"1545-5017","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,15]]},"assertion":[{"value":"2020-09-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-12","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e28983"}}